Pedro Figueiredo

Pedro Figueiredo

Auto-generated profile, based on publicly available information

Pedro Figueiredo

Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2014 in IEEE Transactions on Medical Imaging
Verified
Journal Article
Closed access
AMAlexander V. Mamonov
Alexander V. Mamonov
IFIsabel Figueiredo
Isabel Figueiredo
PFPedro N. Figueiredo
Pedro N. Figueiredo
YTYen-Hsi Richard Tsai
Yen-Hsi Richard Tsai
Colorectal polyps are important precursors to colon cancer, a major health problem. Colon capsule endoscopy is a safe and minimally invasive examination procedure, in which the images of the intestine are obtained via digital cameras on board of a small capsule ingested by a patient. The video sequence is then analyzed for the presence of polyps. We propose an algorithm that relieves the labor of a human operator analyzing the frames in the video sequence. The algorithm acts as a binary classifier, which labels the frame as either containing polyps or not, based on the geometrical analysis and the texture content of the frame.We assume that the polyps are characterized as protrusions that are mostly round in shape. Thus, a best fit ball radius is used as a decision parameter of the classifier. We present a statistical performance evaluation of our approach on a data set containing over 18 900 frames from the endoscopic video sequences of five adult patients. The algorithm achieves 47% sensitivity per frame and 81% sensitivity per polyp at a specificity level of 90%. On average, with a video sequence length of 3747 frames, only 367 false positive frames need to be inspected by an operator.

29 October 2008 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
NANuno Almeida
Nuno Almeida
PFPedro Figueiredo
Pedro Figueiredo
SLSandra Lopes
Sandra Lopes
HGHermano Gouveia
Hermano Gouveia
MLMaximino C. Leitão
Maximino C. Leitão

1 June 2014 in Gastrointestinal Endoscopy
Verified
Journal Article
Closed access
DDDiogo Dias-Silva
Diogo Dias-Silva
PPPedro Pimentel-Nunes
Pedro Pimentel-Nunes
JMJoana Magalhães
Joana Magalhães
RMRicardo Magalhães
Ricardo Magalhães
NVNuno Veloso
Nuno Veloso
MDMário Dinis-Ribeiro
Mário Dinis-Ribeiro

8 June 2021 in United European Gastroenterology Journal
Verified
Journal Article
Open access
PDF file
HCHelena Cortez-Pinto
Helena Cortez-Pinto
RLRodrigo Liberal
Rodrigo Liberal
SLSusana Lopes
Susana Lopes
MMMariana Machado
Mariana Machado
JCJoana Carvalho
Joana Carvalho
FCFilipe Calinas
Filipe Calinas
Background: The current standard of treatment in primary biliary cholangitis (PBC) is ursodeoxycholic acid (UDCA), although a considerable proportion of patients show incomplete response resulting in disease progression.Objective: This study aimed to assess the prevalence of incomplete response to UDCA and determine associated patients' characteristics.Methods: Patients with PBC as main diagnosis were included from a national multicentric patient registry—Liver.pt. Main endpoints included incomplete response to UDCA treatment according to Barcelona, Paris I and Paris II criteria, Globe and UK PBC scores and the association between baseline characteristics and incomplete response according to Paris II criteria.Results: A total of 434 PBC patients were identified, with a mean age of 55 years and 89.2% females. Nearly half of patients were asymptomatic at diagnosis and 93.2% had positive anti‐mitochondrial antibodies. Almost all patients (95.6%) had been prescribed at least one drug for PBC treatment. At the last follow‐up visit, 93.3% were under treatment of which 99.8% received UDCA. Incomplete response to UDCA was observed in 30.7%, 35.3%, 53.7% and 36.4% of patients according to Barcelona, Paris I, Paris II criteria and Globe score, respectively. After adjusting for age and sex, and accordingly to Paris II criteria, the risk for incomplete biochemical response was 25% higher for patients with cirrhosis at diagnosis (odds ratio [OR] = 1.25; 95% confidence interval [95%CI]: 1.02–1.54; p = 0.033) and 35% (95%CI:1.06–1.72; p = 0.016) and 5% (OR = 1.05; 95%CI:1.01–1.10; p = 0.013) for those with elevated gamma‐glutamyl transferase (GGT) and alkaline phosphatase (ALP).Conclusion: A considerable proportion of patients showed incomplete biochemical response to UDCA treatment according to Paris II criteria. Cirrhosis, elevated GGT and ALP at diagnosis were identified as associated risk factors for incomplete response. Early identification of patients at risk of incomplete response could improve treatment care and guide clinical decision to a more careful patient monitorization.

1 September 2017 in European Journal of Gastroenterology & Hepatology
Verified
Journal Article
Closed access
PDF file
MGMarta Gravito-Soares
Marta Gravito-Soares
EGElisa Gravito-Soares
Elisa Gravito-Soares
SLSandra Lopes
Sandra Lopes
GRGraça Ribeiro
Graça Ribeiro
PFPedro Figueiredo
Pedro Figueiredo
Introduction and aim: Spontaneous bacterial peritonitis is the most common infectious complication in cirrhosis. Spontaneous fungal peritonitis is rare and remains unknown. In this work, spontaneous fungal peritonitis as well as risk factors and prognosis are characterized. Patients and methods: A retrospective case–control study of 253 consecutive admissions by peritonitis in cirrhotic patients was carried out between 2006 and 2015. Comparison of patients with spontaneous fungal peritonitis (cases) and spontaneous bacterial peritonitis with positive microbiologic ascitic fluid culture (controls) was performed. Variables such as sociodemographic and clinical features, cirrhosis etiology, liver dysfunction scores, ascitic and laboratory parameters, invasive procedures, and prognosis were evaluated. Results: Of the 231 patients, eight (3.5%) developed spontaneous fungal peritonitis, 62.5% of cases being coinfected with bacteria. Candida spp. was isolated in 87.5% of cases, mainly Candida albicans (37.5%) and C. krusei (25.0%). Patients with spontaneous fungal peritonitis had higher ascitic fluid lactate dehydrogenase (288.4±266.6 vs. 161.0±179.5; P=0.011), blood leukocyte count (15187.5±5432.3 vs. 10969.8±6949.5; P=0.028), blood urea nitrogen (69.8±3.1 vs. 36.3±25.5; P=0.001), higher number of invasive procedures (colonoscopy: 25.0 vs. 0.8%, P=0.001; urinary catheterization: 87.5 vs. 49.6%, P=0.038; nasogastric intubation: 87.5 vs. 26.9%, P=0.001), and longer duration of hospital stay (30.0±32.9 vs. 18.9±17.0 days; P=0.031). No statistical difference was found between the two groups for Model for End-Stage Liver Disease, Model for End-Stage Liver Disease–sodium, and Child–Pugh scores. Spontaneous fungal peritonitis was associated with a worse prognosis, particularly severe sepsis/septic shock (87.5 vs. 42.8%, P=0.023), admission in the gastroenterology intensive care unit (87.5 vs. 24.4%; P=0.001), and overall (62.5 vs. 31.9%; P=0.039) or 30-day mortality (50.0 vs. 24.4%; P=0.034), with a mean diagnosis-death time of 17.6±11.5 days. Conclusion: Despite being a rare condition, spontaneous fungal peritonitis was associated with worse prognosis and higher mortality than SBP. The ascitic fluid lactate dehydrogenase, blood leukocyte count and urea nitrogen, invasive procedures, and longer admission time were independent risk factors for spontaneous fungal peritonitis.

17 November 2007 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
PFPedro Figueiredo
Pedro Figueiredo
NANuno Almeida
Nuno Almeida
CLClotilde Lérias
Clotilde Lérias
SLSandra Lopes
Sandra Lopes
HGHermano Gouveia
Hermano Gouveia
DFDiniz Freitas
Diniz Freitas